Atrys Health, S.A. (ATRY.MC)
Provides diagnostic testing, cancer treatment, and telemedicine services across Spain and Latin America.
2.57+0.02%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-10.3%
The outlook
ATRY.MC is trading near the lower end of its 52-week range and below both its 50- and 200-day moving averages, signaling a downtrend. Analyst sentiment leans bearish overall, though the average price target sits roughly 88% above the current price, indicating a significant gap between current valuations and analyst expectations.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range20% of the way from its 52-week low to high
Price targetAvg target +88% vs current price
Analyst price target
~12-month · 3 analysts4.83average target+88.4% vs now
Now 2.57
Low 4.00High 5.50
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$194.7M
52-wk high
3.59
52-wk low
2.31
50-day avg
2.61
200-day avg
2.83
Trailing P/E
—